Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Depomed Inc (NASDAQ:DEPO)

23.89
Delayed Data
As of 3:59pm ET
 -0.64 / -2.61%
Today’s Change
12.25
Today|||52-Week Range
25.50
+31.77%
Year-to-Date
How Much Could DepoMed Fetch in a Deal?
Sep 22 / MotleyFool.com - Paid Partner Content
Why DepoMed's Shares Are Jumping 12% Today
Sep 16 / MotleyFool.com - Paid Partner Content
Why Avis Budget Group, Depomed, and Community Health Systems Jumped Today
Sep 16 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close24.53
Today’s open24.30
Day’s range23.52 - 24.53
Volume2,204,412
Average volume (3 months)1,270,499
Market cap$1.5B
Dividend yield--
Data as of 3:59pm ET, 09/29/2016

Growth & Valuation

Earnings growth (last year)-161.46%
Earnings growth (this year)+72.28%
Earnings growth (next 5 years)+19.00%
Revenue growth (last year)-12.20%
P/E ratioNM
Price/Sales3.18
Price/Book4.73

Competitors

 Today’s
change
Today’s
% change
HCMHutchison China Medi...-0.10-0.79%
CBMCambrex Corp-1.47-3.23%
CLVSClovis Oncology Inc-1.70-4.68%
AXONAxovant Sciences Ltd+0.25+1.78%
Data as of 4:02pm ET, 09/29/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)$0.37
Annual revenue (last year)$342.7M
Annual profit (last year)-$75.7M
Net profit margin-22.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
James A. Schoeneck
Chief Financial Officer &
Senior Vice President
August J. Moretti
Corporate headquarters
Newark, California

Forecasts

Search for Jobs